WashIn /WashOut Procedure To Prevent Agitation During Recovery After Inhalational Anesthesia With Sevoflurane
OPERA
1 other identifier
interventional
200
1 country
3
Brief Summary
Inhalation anesthesia is the most frequently used technique and is performed in around 70% of surgeries worldwide. Sevoflurane is the most frequently used halogenated anesthetic and is used in 2/3 of the cases. The anesthetic strength of inhalation agents was established in the classic work of Eger and colleagues who determined the minimum alveolar concentration (MAC) of an inhaled anesthetic at atmospheric pressure, necessary to prevent a motor reaction in response to a pain stimulus in 50% of patients. Agitation is a frequent anesthesia complications and it not only lengthens the period of post anesthetic awakening and need for advance monitoring of the patient, but may be a predisposing factor in the development of postoperative delirium (POD) and postoperative cognitive dysfunction (POCD) which are independent predictors of increased mortality, prolonged treatment in the ICU and hospital, and prolonged social adaptation of the operated patients.(The ability of the patient to serve themselves independently.). There is a fairly popular point of view that there is no specific prophylaxis or treatment of postoperative agitation. However, a variant of anesthesia induction with sevoflurane was recently proposed, which reduced the frequency of agitation in children from 24.7% to 4.4%. The technique consisted in interrupting anesthesia at the moment of loss of consciousness, awakening the patient and subsequently performing re-induction. Since this technique might be time consuming in the busiest period of a surgical theatre and not safe if performed with the airways still unsecured it is advisable to shift the Wash In/Wash Out procedure to the stage of awakening at the end of surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2021
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 15, 2021
CompletedFirst Posted
Study publicly available on registry
February 21, 2021
CompletedStudy Start
First participant enrolled
March 10, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 25, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 25, 2026
CompletedJuly 8, 2025
June 1, 2025
4 years
February 15, 2021
July 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The effect of "Wash In / WashOut" procedure on the incidence of postoperative agitation after anesthesia with sevoflurane.
the patient scores +2 or more points on the RASS scale in one or more measurements, then he is diagnosed with agitation.
during 30 minutes after awaking
To estimate changes in the incidence of postoperative agitation on the RASS scale
incidence of postoperative agitation in control group - incidence of postoperative agitation in study group
during 30 minutes after awaking
Secondary Outcomes (6)
To estimate changes in the incidence of postoperative delirium on the scales CAM-ICU, ICDSC
3 days after surgery twice a day (a.m. and p.m.)
To estimate changes in the incidence of postoperative cognitive impairment
on the 7th day after surgery
To estimate the incidence of postoperative nausea and vomiting, the need of using of antiemetics
Since end of surgery prior to hospital discharge
To estimate patient satisfaction with anesthesia on the ISAS scale
At third postoperative day
Length of stay in ICU
ICU discharged
- +1 more secondary outcomes
Study Arms (2)
Study group
EXPERIMENTALA group of patients in relation to whom the "Wash In / WashOut" procedure will be applied. In this group we stop the supply of sevoflurane to the first signs of awakening and record the level of sevoflurane , then we resume the supply of sevoflurane to the end-tidal concentration of 1 MAC maintain the anesthesia for 5 min and stop the supply of sevoflurane to the first signs of awakening again, then we resume the supply of sevoflurane to the end-tidal concentration of 1 MAC maintain the anesthesia for 5 min and finally ( the third time) stop supplying sevoflurane and extubate patient after recovery of muscle tone, spontaneous breathing and consciousness.
Control group
NO INTERVENTIONA group of patients in relation to whom will be applied the traditional method of recovery from anesthesia. In this group during the period of awakening we stop supplying sevoflurane and extubate patient after recovery of muscle tone, spontaneous breathing and consciousness.
Interventions
According "Wash In / WashOut" procedure in study group we stop the supply of sevoflurane to the first signs of awakening and record the level of sevoflurane , then we resume the supply of sevoflurane to the end-tidal concentration of 1 MAC maintain the anesthesia for 5 min and stop the supply of sevoflurane to the first signs of awakening again, then we resume the supply of sevoflurane to the end-tidal concentration of 1 MAC maintain the anesthesia for 5 min and finally ( the third time) stop supplying sevoflurane and extubate patient after recovery of muscle tone, spontaneous breathing and consciousness.
Eligibility Criteria
You may qualify if:
- Written informed consent from participants
- Age ≥ 18 years
- Planned open abdominal surgery
- General anesthesia
You may not qualify if:
- Pregnant patients and breastfeeding patients
- Mental disorders
- Epilepsy, Parkinson disease, Alzheimer, peripheral nerve and neuromuscular junction pathology (amyotrophic lateral sclerosis, Guillain-Barre Syndrome, myasthenia gravis et cet.)
- Use of antidepressants, antipsychotics, sedatives, psychoactive drugs within a month before surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Moscow Scientific Clinical Center
Moscow, 111123, Russia
Moscow Regional Research and Clinical Institute Moniki n.a. M.F. Vladimirskiy
Moscow, 129110, Russia
Clinical hospital №1 of the I.M. Sechenov First Moscow State Medical University (Sechenov University)
Moscow, Russia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Valery Likhvantsev
I.M. Sechenov First Moscow State Medical University (Sechenov University); Head of Research V. Negovsky Reanimatology Research Institute
- STUDY CHAIR
Giovanni Landoni
San Raffaele Scientific Institute
- PRINCIPAL INVESTIGATOR
Pavel Bagdasarov
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 15, 2021
First Posted
February 21, 2021
Study Start
March 10, 2021
Primary Completion
February 25, 2025
Study Completion
February 25, 2026
Last Updated
July 8, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share
Our Local Ethical Committee disable us to do it